Clinical Trials Directory

Trials / Completed

CompletedNCT06368479

Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,400 (actual)
Sponsor
bioLytical Laboratories · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective cross-sectional study in which surgically non-invasive sample-taking is done only for the purpose of testing the samples on iStatis HBsAg Test at the point of care.

Detailed description

Participants are prospctively recruited and enrolled to participate in the study. The Capillary (fingerstick) whole blood, and venous whole blood samples (in serum separating tube (SST) and Ethylenediaminetetraacetic acid (EDTA) tube) are collected by a healthcare professional. Serum and plasma samples will be extracted through laboratory processing of the collected serum separating tube and Ethylenediaminetetraacetic acid VWB, respectively. The collected samples of capillary will be tested on iStatis HBsAg Test. The collected Ethylenediaminetetraacetic acid and serum separating tube VWB will be shipped to the central laboratory to appropriately process and extract serum and plasma samples. Ethylenediaminetetraacetic acid VWB, plasma and serum will be tested on iStatis HBsAg Test in the laboratory. An aliquot of the obtained plasma sample will be further tested for reference and confirmatory testing. The results from iStatis HBsAg Test results will not be used for participant management decisions.

Conditions

Interventions

TypeNameDescription
DEVICEiStatis HBsAg TestCapillary (fingerstick) blood, EDTA venous whole blood, serum and plasma samples to be tested on the iStatis HBsAg Test at the point of care setting.

Timeline

Start date
2024-03-19
Primary completion
2024-07-19
Completion
2024-07-19
First posted
2024-04-16
Last updated
2025-02-21

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT06368479. Inclusion in this directory is not an endorsement.